News | Dermatology

News

Daily Vaseline use could be cost-effective way to prevent eczema

Recent attention has turned to ways to prevent atopic dermatitis, which is associated with significant expenditure as well as comorbidities, from developing in children.…

Published: 6 February 2017

News

European drug safety agency concludes Valette can be used for moderate acne

The hormonal contraceptive Valette (dienogest/ethinylestradiol; Bayer) can continue to be used to treat women with moderate acne, following a safety review by the European Medicines Agency (EMA). …

Published: 1 February 2017

News

Eucrisa approved for eczema in US

A new treatment for mild-to-moderate atopic dermatitis has been approved by the US Food and Drug Administration for use in patients aged two years and older. Eucrisa (Anacor Pharmaceuticals, recently acquired by Pfizer) is applied topically twice daily. It is a phosphodiesterase 4 (PDE-4) inhi…

Published: 19 December 2016

Opinion

Why we need more over-the-counter products to treat acne

Approval of the first over-the-counter topical retinoid in the United States is a welcome move and should be replicated in other countries.…

Published: 7 October 2016

News

Vitamin D levels can affect aggressiveness of melanomas

Patients with malignant melanoma should not be advised to stay out of the sun without taking measures to ensure healthy levels of vitamin D, according to Julia Newton-Bishop, professor of dermatology at the University of Leeds.…

Published: 11 August 2016

News

Efficacy is not highest priority for sunscreen buyers

Healthcare professionals should advise consumers on adequate photoprotection, new study concludes.…

Published: 18 July 2016

News

FDA approves first OTC retinoid for acne

The first retinoid acne treatment to be made available over the counter in the United States has been approved by the US Food and Drug Administration.…

Published: 13 July 2016

News

PCSK9 inhibiting cholesterol drugs among latest NICE approvals

Two new drugs used to treat patients with high cholesterol when other lipid lowering drugs are either ineffective or cannot be tolerated have been recommended for use on the NHS in England.…

Published: 22 June 2016

News

Ixekizumab clears psoriasis in up to 80% of patients

After 12 weeks of treatment with ixekizumab, more than three-quarters of patients had clear or minimal psoriasis.…

Published: 22 June 2016

News

Combination immunotherapy for advanced melanoma gets early approval from NICE

The immunotherapy combination nivolumab/ipilimumab has been recommended for patients with advanced malignant melanoma, according to draft guidance from the National Institute for Health and Care Excellence (NICE). The approval means that patients in England and Wales will be the first in…

Published: 17 June 2016